Kirr Marbach & Co
RPRX icon

Kirr Marbach & Co’s Royalty Pharma RPRX Stock Holding History

Kirr Marbach & Co’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$14M Sell
239,136
-325
-0.1% -$19.2K 2.64% 13
2026
Q2 		$13.4M Buy
239,461
+1,566
+0.7% +$81.5K 2.26% 14
2026
Q1 		$11.4M Buy
+237,895
New +$10.4M 2.08% 19

Other funds holding RPRX

Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
Daiwa Securities Group
Daiwa Securities Group Tokyo, Japan $53.6B AUM 32.29% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Wedge Capital Management
Wedge Capital Management Charlotte, North Carolina $5.72B AUM 38.26% 1-Year Est. Return
Achmea Investment Management
Achmea Investment Management Zeist, Netherlands $12.6B AUM 25.68% 1-Year Est. Return
Eastern Bank
Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return
Fideuram Asset Management (Ireland)
Fideuram Asset Management (Ireland) Dublin 1 $4.57B AUM 30.36% 1-Year Est. Return
Todd Asset Management
Todd Asset Management Louisville, Kentucky $5.51B AUM 33.77% 1-Year Est. Return

Kirr Marbach & Co's RPRX Position: Q3 2026 in Review

Kirr Marbach & Co reduced its Royalty Pharma (RPRX) stake by 0.14% in Q3 2026, selling an estimated $19.2K and leaving 239,136 shares worth $14M. The position accounts for 2.64% of the portfolio, ranked #13.

Kirr Marbach & Co first reported a position in RPRX in Q1 2026 and has held it in 3 quarters since. 208 funds tracked by Wall St. Rank hold RPRX as of Q3 2026.

  • Kirr Marbach & Co held 239,136 shares of Royalty Pharma worth $14M as of Q3 2026.
  • Kirr Marbach & Co sold 325 Royalty Pharma shares in Q3 2026, an estimated $19.2K.
  • Royalty Pharma made up 2.64% of Kirr Marbach & Co's portfolio in Q3 2026, its #13 holding.
  • Kirr Marbach & Co first reported a position in Royalty Pharma in Q1 2026 and has held it in 3 quarters since.
  • 208 funds tracked by Wall St. Rank held Royalty Pharma as of Q3 2026.

Based on Kirr Marbach & Co's 13F filing for Q3 2026, filed 20 Oct 2026.